Shanxi Zhendong Pharmaceutical (300158) — Capital Reinvestment Ratio

Latest as of June 2024: 14.80x

Shanxi Zhendong Pharmaceutical (300158) has a Capital Reinvestment Ratio of 14.80x as of June 2024, meaning it reinvests 15% of its operating cash flow (CN¥4.69 Million) in capital expenditures (CN¥69.40 Million). See debt-free asset ratio of Shanxi Zhendong Pharmaceutical to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

14.80x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥4.69 Million
CNY

Capital Expenditures

CN¥69.40 Million
CNY

Data as of

Jun 2024
Most recent filing

Shanxi Zhendong Pharmaceutical Capital Reinvestment Ratio (2007–2022)

This chart tracks Shanxi Zhendong Pharmaceutical's Capital Reinvestment Ratio across 13 annual periods. Check how aggressively does Shanxi Zhendong Pharmaceutical reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Shanxi Zhendong Pharmaceutical (2007–2022)

Year-by-year Capital Reinvestment Ratio for Shanxi Zhendong Pharmaceutical from 2007 to 2022. For live market cap and broader valuation context, see market value of Shanxi Zhendong Pharmaceutical.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2022 1.69x CN¥86.31 Million CN¥145.81 Million ▲ +216.9%
2021 0.53x CN¥284.45 Million CN¥151.66 Million ▼ -35.7%
2020 0.83x CN¥221.94 Million CN¥183.96 Million ▲ +697.6%
2019 0.10x CN¥186.35 Million CN¥19.37 Million ▼ -32.9%
2018 0.15x CN¥154.48 Million CN¥23.92 Million ▼ -85.4%
2017 1.06x CN¥45.09 Million CN¥47.93 Million ▲ +244.1%
2015 0.31x CN¥151.84 Million CN¥46.92 Million ▼ -84.3%
2014 1.97x CN¥73.23 Million CN¥144.15 Million ▲ +6.9%
2012 1.84x CN¥189.40 Million CN¥348.75 Million ▼ -25.5%
2010 2.47x CN¥32.40 Million CN¥80.09 Million ▲ +273.1%
2009 0.66x CN¥42.28 Million CN¥28.01 Million ▼ -25.1%
2008 0.88x CN¥33.18 Million CN¥29.35 Million ▲ +170.4%
2007 0.33x CN¥128.65 Million CN¥42.07 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow